Isentress and Oedema - a phase IV clinical study of FDA data

Summary:

Oedema is reported as a side effect among people who take Isentress (raltegravir potassium), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Norvir, and have Arrhythmias.

The phase IV clinical study analyzes which people have Oedema when taking Isentress. It is created by eHealthMe based on reports of 16,310 people who have side effects when taking Isentress from the FDA, and is updated regularly.

What is Isentress?

Isentress has active ingredients of raltegravir potassium. It is often used in hiv infection. eHealthMe is studying from 16,529 Isentress users. Check the latest studies of Isentress.

What is Oedema?

Oedema (fluid collection in tissue) is found to be associated with 2,171 drugs and 2,311 conditions by eHealthMe. Check the latest studies of Oedema.

On Jul, 20, 2026

16,310 people reported to have side effects when taking Isentress.
Among them, 40 people (0.25%) have Oedema.

Among these 40 people:

How long have people been on Isentress when they have Oedema? *

What is the gender of people who have Oedema when taking Isentress? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Oedema when taking Isentress? *

What are other drugs people take besides Isentress? *

What are other side effects people have besides Oedema? *

Itching: 7 people, 17.50%
Weight Increased: 7 people, 17.50%
Rashes (redness): 6 people, 15.00%
Anaemia (lack of blood): 6 people, 15.00%
Renal Impairment (severely reduced kidney function): 5 people, 12.50%
Nausea And Vomiting: 5 people, 12.50%
Headache (pain in head): 4 people, 10.00%
Ascites (accumulation of fluid in the abdominal cavity): 4 people, 10.00%
Iron Deficiency Anaemia: 4 people, 10.00%
Pain: 4 people, 10.00%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 10.00%
Essential Tremor: 4 people, 10.00%
Arrhythmias (irregular heartbeat): 4 people, 10.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 5.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 5.00%
Gastritis (inflammation of stomach): 2 people, 5.00%
Disseminated Tuberculosis: 2 people, 5.00%
Cryptococcosis (potentially fatal fungal disease): 2 people, 5.00%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 1 person, 2.50%
Hepatitis C: 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Isentress and have Oedema?

- Check whether Oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Isentress:

Isentress (16,529 reports)

Oedema treatments and more:

Oedema (78,747 reports)

Browse all side effects of Isentress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oedema:

Oedema (2,171 drugs)

Browse all the conditions that are associated with Oedema:

Oedema (2,311 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raltegravir potassium (the active ingredients of Isentress) and Isentress (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.